The Journal of Practical Medicine >

2024 , Vol. 40 >Issue 2: 133 - 139

DOI: https://doi.org/10.3969/j.issn.1006-5725.2024.02.002

Feature Reports：carcinoma of cervix

Generation of MCM2 gene inducible knockout cervical cancer HeLa cells and its effect on DNA replication

  • Ping LI ,
  • Tuo TANG ,
  • Aixue ZHENG ,
  • Luping ZHANG ,
  • Tao WANG ,
  • Xian HONG ,
  • Zhihui DENG
Expand
  • Institute of Medicine and Pharmacy，Qiqihar Medical University，Qiqihar 161006，China

Received date: 2023-08-09

  Online published: 2024-03-06

Fold

Abstract

Objective To generate minichromosome maintenance protein 2 （MCM2） gene knockout cervical cancer HeLa cell lines using inducible CRISPR/Cas9 technology， and to explore the effect of MCM2 on DNA replication and replication stress. Methods The inducible CRISPR/Cas9 system， TLCV2， was used to construct MCM2 knockout HeLa cell lines. And the cell lines were divided into control group （Control）， knockout group 1 （KO1）， and knockout group 2 （KO2）. Western blot， Edu incorporation experiment， real-time quantitative PCR （qPCR）， immunofluorescence and MTT assay were used to analyze the effects of MCM2 knockout on DNA replication and replication stress induced by hydroxyurea. Results The CRISPR/Cas9 system successfully knocked out the MCM2 gene after induction， and MCM2 knockout affected the stability of MCM2-7 complex. Compared with the control cells， MCM2 knockout cells had a dramatic decrease in the capacity of DNA replication， and the mRNA levels of Cyclin A1， Cyclin E1 and CDK4. Under DNA replication stress， MCM2 knockout cells decreased cell viability， DNA damage repair capacity， and increased genomic instability compared with control cells. Conclusion Knockout of MCM2 gene reduces the DNA replication capacity of HeLa cells under normal conditions and cell viability under replication stress. This study successfully generates MCM2 gene inducible knockout HeLa cell lines， laying the foundation for further research on the role and biological function of MCM2 gene in the occurrence and progression of cervical cancer.

Key words： MCM2; gene knockout; cervical cancer; HeLa cell; DNA replication

Cite this article

Ping LI , Tuo TANG , Aixue ZHENG , Luping ZHANG , Tao WANG , Xian HONG , Zhihui DENG . Generation of MCM2 gene inducible knockout cervical cancer HeLa cells and its effect on DNA replication[J]. The Journal of Practical Medicine, 2024 , 40(2) : 133 -139 . DOI: 10.3969/j.issn.1006-5725.2024.02.002

References

1 LEMAN A R， NOGUCHI E. The replication fork： understanding the eukaryotic replication machinery and the challenges to genome duplication ［J］. Genes （Basel）， 2013， 4（1）：1-32. doi:10.3390/genes4010001
2 SCLAFANI R A， HOLZEN T M. Cell cycle regulation of DNA replication ［J］. Annu Rev Genet， 2007， 41：237-280. doi:10.1146/annurev.genet.41.110306.130308
3 YARDIMCI H， WALTER J C. Prereplication-complex formation： a molecular double take ［J］. Nat Struct Mol Biol， 2014， 21（1）：20-25. doi:10.1038/nsmb.2738
4 TOGNETTI S， RIERA A， SPECK C. Switch on the engine： how the eukaryotic replicative helicase MCM2-7 becomes activated ［J］. Chromosoma， 2015， 124（1）：13-26. doi:10.1007/s00412-014-0489-2
5 YU S， WANG G， SHI Y， et al. MCMs in Cancer： Prognostic Potential and Mechanisms ［J］. Anal Cell Pathol （Amst）， 2020， 2020：3750294. doi:10.1155/2020/3750294
6 WU B， XI S. Bioinformatics analysis of the transcriptional expression of minichromosome maintenance proteins as potential indicators of survival in patients with cervical cancer ［J］. BMC Cancer， 2021， 21（1）：928. doi:10.1186/s12885-021-08674-y
7 KAUR G， BALASUBRAMANIAM S D， LEE Y J， et al. Minichromosome Maintenance Complex （MCM） Genes Profiling and MCM2 Protein Expression in Cervical Cancer Development ［J］. Asian Pac J Cancer Prev， 2019， 20（10）：3043-3049. doi:10.31557/apjcp.2019.20.10.3043
8 ISSAC M S M， YOUSEF E， TAHIR M R， et al. MCM2， MCM4， and MCM6 in Breast Cancer： Clinical Utility in Diagnosis and Prognosis ［J］. Neoplasia， 2019， 21（10）：1015-1035. doi:10.1016/j.neo.2019.07.011
9 WANG Y， LI Y， ZHANG W Y， et al. mRNA expression of minichromosome maintenance 2 in colonic adenoma and adenocarcinoma ［J］. Eur J Cancer Prev， 2009， 18（1）：40-45. doi:10.1097/cej.0b013e32830c8d5a
10 TANG Z， YANG Y， CHEN W， et al. Demethylation at enhancer upregulates MCM2 and NUP37 expression predicting poor survival in hepatocellular carcinoma patients ［J］. J Transl Med， 2022， 20（1）：49. doi:10.1186/s12967-022-03249-2
11 SUN Y， CHENG Z， LIU S. MCM2 in human cancer： functions， mechanisms， and clinical significance ［J］. Mol Med， 2022， 28（1）：128. doi:10.1186/s10020-022-00555-9
12 张颖，吴月玲.宫颈癌的免疫治疗：精准医学的到来［J］.实用医学杂志，2022，38（15）：1856-1859. doi:10.3969/j.issn.1006-5725.2022.15.002
13 薛栋，孙祺，邬君义，等.利用 CRISPR/Cas9 系统敲除 ITGB6 基因对人结肠癌 HT-29 细胞生物学行为的影响［J］.实用医学杂志，2023，39（5）：585-590.
14 BARGER C J， BRANICK C， CHEE L， et al. Pan-Cancer Analyses Reveal Genomic Features of FOXM1 Overexpression in Cancer ［J］. Cancers （Basel）， 2019， 11（2）：251. doi:10.3390/cancers11020251
15 HONG X， WANG T， DU J， et al. ITRAQ-based quantitative proteomic analysis reveals that VPS35 promotes the expression of MCM2-7 genes in HeLa cells［J］. Sci Rep， 2022， 12（1）：9700. doi:10.1038/s41598-022-13934-3
16 HE Y， HU S， ZHONG J， et al. Identification of significant genes signatures and prognostic biomarkers in cervical squamous carcinoma via bioinformatic data ［J］. Peer J， 2020， 8：e10386. doi:10.7717/peerj.10386
17 TSUJI T， FICARRO S B， JIANG W. Essential role of phosphorylation of MCM2 by Cdc7/Dbf4 in the initiation of DNA replication in mammalian cells ［J］. Mol Biol Cell， 2006， 17（10）：4459-4472. doi:10.1091/mbc.e06-03-0241
18 ZHANG X， TENG Y， YANG F， et al. MCM2 is a therapeutic target of lovastatin in human non-small cell lung carcinomas ［J］. Oncol Rep， 2015， 33（5）：2599-2605. doi:10.3892/or.2015.3822
19 杨才平，张强，韩婷婷，等. 干扰微小染色体维持基因表达对人胰腺癌细胞增殖和迁移的干预作用及其机制［J］. 山东医药，2023， 63（2）：24-27. doi:10.3969/j.issn.1002-266X.2023.02.006
20 LAU K M， CHAN Q K， PANG J C， et al. Minichromosome maintenance proteins 2， 3 and 7 in medulloblastoma： overexpression and involvement in regulation of cell migration and invasion ［J］. Oncogene， 2010， 29（40）：5475-5489. doi:10.1038/onc.2010.287
21 LIU Z， LI J， CHEN J， et al. MCM family in HCC： MCM6 indicates adverse tumor features and poor outcomes and promotes S/G2 cell cycle progression ［J］. BMC Cancer， 2018， 18（1）：200. doi:10.1186/s12885-018-4056-8
22 QIU Y T， WANG W J， ZHANG B， et al. MCM7 amplification and overexpression promote cell proliferation， colony formation and migration in esophageal squamous cell carcinoma by activating the AKT1/mTOR signaling pathway ［J］. Oncol Rep， 2017， 37（6）：3590-3596. doi:10.3892/or.2017.5614
23 GAO C， GU X， CHEN Y， et al. Identification of Potential Prognostic and Predictive Biomarkers for Immune-Checkpoint Inhibitor Response in Small Cell Lung Cancer ［J］. Med Sci Monit， 2021， 27：e932275. doi:10.12659/msm.932275
24 MISONO S， MIZUNO K， SUETSUGU T， et al. Molecular Signature of Small Cell Lung Cancer after Treatment Failure： The MCM Complex as Therapeutic Target ［J］. Cancers （Basel）， 2021， 13（6）：1187. doi:10.3390/cancers13061187
25 DENG M， SUN J， XIE S， et al. Inhibition of MCM2 enhances the sensitivity of ovarian cancer cell to carboplatin ［J］. Mol Med Rep， 2019， 20（3）：2258-2266.
Options
Outlines

/

〈 〉